Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Drug Design MeSH Descriptor Data 2025


MeSH Heading
Drug Design
Tree Number(s)
E05.290.563.250
Unique ID
D015195
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D015195
Annotation
do not confuse with DESIGNER DRUGS
Scope Note
The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis.
Entry Term(s)
Computer-Aided Drug Design
Computerized Drug Design
Drug Modeling
Pharmaceutical Design
NLM Classification #
QV 745
Previous Indexing
Chemistry, Pharmaceutical (1966-1988)
Drugs (1966-1988)
See Also
Computer-Aided Design
Designer Drugs
Public MeSH Note
89
History Note
89
Date Established
1989/01/01
Date of Entry
1988/04/21
Revision Date
2022/05/23
Drug Design Preferred
Drug Modeling Narrower
Computer-Aided Drug Design Narrower
page delivered in 0.145s